U.S. flag

An official website of the United States government

GTR Home > Tests > LSD/X-ALD Newborn Screen, BS

Performance Characteristics

Availability

Help

  • Entire test performed in-house

Analytical Validity

Help

Accuracy was assessed by analysis of positive and negative specimens; all samples were clinically concordant. Intra assay precision was performed at 7 levels: CV results ranged from 3%-244% where higher CVs were obtained for physiologically low analyte concentrations near zero (N=20 each). Inter assay precision was performed at 3 levels: CV results ranged from 7%-29% where higher CVs were obtained for physiologically low analyte concentrations near zero (N=20 each).

Citations

Not provided

Assay Limitation(s)

Help

Carrier status (heterozygosity) for these conditions cannot be reliably detected. A positive test result is strongly suggestive of a diagnosis but requires follow-up by stand-alone biochemical or molecular assay, which is best coordinated by local genetics providers. Some cases with milder or later onset disease may not display sufficiently abnormal results during the newborn period and, therefore, yield false-negative results.

Internal Test Validation Method

Help

This test was laboratory developed, and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements.

Citations

Not provided

Proficiency Testing (PT)

Is proficiency testing performed for this test? Help
Yes
Method used for proficiency testingHelp
Formal PT program & Inter-Laboratory
PT ProviderHelp
Centers for Disease Control and Prevention Newborn Screening Quality Assurance Program, CDC DLS
PT Description
Formal PT program and Inter-laboratory comparison with outside laboratory(s)

FDA Regulatory Clearances of the Test

Help
FDA Category Designation
FDA exercises enforcement discretion

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.